As of 2024-12-11, the Relative Valuation of Oncodesign SA (ALONC.PA) is (10.80) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 14.42 EUR, the upside of Oncodesign SA based on Relative Valuation is -174.9%.
The range of the Relative Valuation is (21.53) - 3.35 EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.1x - 39.5x | 27.9x |
| Forward P/E multiples | 28.6x - 36.1x | 35.4x |
| Fair Price | (21.53) - 3.35 | (10.80) |
| Upside | -249.3% - -76.8% | -174.9% |
| Date | P/E |